Data bases, registries and cohorts’ results are academic assets that can be goldmines to the industry. To what extent do they spark the interest of industrial players? How to maximise the value of such databases and registries through collaborations to discover new therapies?

Speakers
Jürgen Walkenhorst - PROvendis

Continue your tour